ChIP-Seq (H3K4me3, H3K4me1, H3K9me3, H3K27ac, H3K27me3, H3K36me3, Input) data for HL60 cell line generated at Centre for Epigenome Mapping Technologies, Genome Sciences Center, B.C. Cancer Agency.

CEMT: Data Access Policy

European Genome-Phenome Archivec/o European Bioinformatics InstituteWellcome Trust Genome CampusHinxtonCambridgeCB10 1SDUnited KingdomTo whom it may concern,This document refers to the data set, EGAS00001000552, which has been submitted to the European Genome Archive (EGA) for the controlled access by legitimate academic institutions that have agreed to comply with the terms of a Data Access Agreement drafted by the British Columbia Cancer Agency Branch herein represented by the Technology Development Office of the Provincial Health Services Authority. There are a number of steps that a researcher must take to obtain access to this data and the process is overseen by the Technology Development Office - contact Karen Forrester (karen.forrester@bccancer.ca) or Susan Grose (sgrose@bccancer.bc.ca) or our general email address TDOadmin@phsa.ca Please be advised that Sitanshu Gakkhar (sgakkhar@bcgsc.ca) and Brad Davis (bdavis@bcgsc.ca) are authorized to upload data to the EGA for archiving and distribution as part of your submission process, which will enable approved researchers to have encrypted access to the data. We can confirm that this submission is consistent with the informed consent of the participants of the study or has been granted ethical approval and is in accordance with the applicable laws and regulations.Sincerely,Steven Jones, Professor, FRSCAssociate Director and Head, BioinformaticsCanada’s Michael Smith Genome Sciences Centre, BC Cancer AgencyProfessor, Medical Genetics, University of British ColumbiaProfessor, Molecular Biology & Biochemistry, Simon Fraser University